These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 25495724)

  • 1. Biocatalytic route to chiral acyloins: P450-catalyzed regio- and enantioselective α-hydroxylation of ketones.
    Agudo R; Roiban GD; Lonsdale R; Ilie A; Reetz MT
    J Org Chem; 2015 Jan; 80(2):950-6. PubMed ID: 25495724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 catalyzed oxidative hydroxylation of achiral organic compounds with simultaneous creation of two chirality centers in a single C-H activation step.
    Roiban GD; Agudo R; Reetz MT
    Angew Chem Int Ed Engl; 2014 Aug; 53(33):8659-63. PubMed ID: 24590553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CH-activating oxidative hydroxylation of 1-tetralones and related compounds with high regio- and stereoselectivity.
    Roiban GD; Agudo R; Ilie A; Lonsdale R; Reetz MT
    Chem Commun (Camb); 2014 Nov; 50(92):14310-3. PubMed ID: 25168091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regio- and stereoselective hydroxylation of 10-undecenoic acid with a light-driven P450 BM3 biocatalyst yielding a valuable synthon for natural product synthesis.
    Kato M; Nguyen D; Gonzalez M; Cortez A; Mullen SE; Cheruzel LE
    Bioorg Med Chem; 2014 Oct; 22(20):5687-91. PubMed ID: 24938497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P450(BM3) on steroids: the Swiss Army knife P450 enzyme just gets better.
    Wong LL
    Chembiochem; 2011 Nov; 12(17):2537-9. PubMed ID: 21998091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving P450pyr Monooxygenase for Regio- and Stereoselective Hydroxylations.
    Yang Y; Li Z
    Chimia (Aarau); 2015; 69(3):136-41. PubMed ID: 26507217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regio- and stereoselectivity of P450-catalysed hydroxylation of steroids controlled by laboratory evolution.
    Kille S; Zilly FE; Acevedo JP; Reetz MT
    Nat Chem; 2011 Aug; 3(9):738-43. PubMed ID: 21860465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P450 BM3-Catalyzed Regio- and Stereoselective Hydroxylation Aiming at the Synthesis of Phthalides and Isocoumarins.
    Holec C; Hartrampf U; Neufeld K; Pietruszka J
    Chembiochem; 2017 Apr; 18(7):676-684. PubMed ID: 28107587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are branched chain fatty acids the natural substrates for P450(BM3)?
    Cryle MJ; Espinoza RD; Smith SJ; Matovic NJ; De Voss JJ
    Chem Commun (Camb); 2006 Jun; (22):2353-5. PubMed ID: 16733577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Dynamics and QM/MM Calculations Predict the Substrate-Induced Gating of Cytochrome P450 BM3 and the Regio- and Stereoselectivity of Fatty Acid Hydroxylation.
    Dubey KD; Wang B; Shaik S
    J Am Chem Soc; 2016 Jan; 138(3):837-45. PubMed ID: 26716578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active site substitution A82W improves the regioselectivity of steroid hydroxylation by cytochrome P450 BM3 mutants as rationalized by spin relaxation nuclear magnetic resonance studies.
    Rea V; Kolkman AJ; Vottero E; Stronks EJ; Ampt KA; Honing M; Vermeulen NP; Wijmenga SS; Commandeur JN
    Biochemistry; 2012 Jan; 51(3):750-60. PubMed ID: 22208729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving regio- and enantioselectivity of P450-catalyzed oxidative CH activation of small functionalized molecules by structure-guided directed evolution.
    Agudo R; Roiban GD; Reetz MT
    Chembiochem; 2012 Jul; 13(10):1465-73. PubMed ID: 22711296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxylation of non-substituted polycyclic aromatic hydrocarbons by cytochrome P450 BM3 engineered by directed evolution.
    Sideri A; Goyal A; Di Nardo G; Tsotsou GE; Gilardi G
    J Inorg Biochem; 2013 Mar; 120():1-7. PubMed ID: 23262457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined photoredox/engineered P450 enzymatic direct dioxygen-functionalization of arylalkanes to chiral acyloins.
    Wang J; Wang H; Wei C; Zhang L; Cui B; Wang Z; Zhang Y; Wan N; Aisa HA; Chen Y
    Org Biomol Chem; 2022 Nov; 20(46):9085-9092. PubMed ID: 36354366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An efficient route to selective bio-oxidation catalysts: an iterative approach comprising modeling, diversification, and screening, based on CYP102A1.
    Seifert A; Antonovici M; Hauer B; Pleiss J
    Chembiochem; 2011 Jun; 12(9):1346-51. PubMed ID: 21591046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
    Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
    Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3.
    Peters MW; Meinhold P; Glieder A; Arnold FH
    J Am Chem Soc; 2003 Nov; 125(44):13442-50. PubMed ID: 14583039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Enzymatic Route to α-Tocopherol Synthons: Aromatic Hydroxylation of Pseudocumene and Mesitylene with P450 BM3.
    Dennig A; Weingartner AM; Kardashliev T; Müller CA; Tassano E; Schürmann M; Ruff AJ; Schwaneberg U
    Chemistry; 2017 Dec; 23(71):17981-17991. PubMed ID: 28990705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P450 BM3 crystal structures reveal the role of the charged surface residue Lys/Arg184 in inversion of enantioselective styrene epoxidation.
    Shehzad A; Panneerselvam S; Linow M; Bocola M; Roccatano D; Mueller-Dieckmann J; Wilmanns M; Schwaneberg U
    Chem Commun (Camb); 2013 May; 49(41):4694-6. PubMed ID: 23589805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of engineered cytochrome P450 mutants as biocatalysts for the synthesis of benzylic and aromatic metabolites of fenamic acid NSAIDs.
    Venkataraman H; Verkade-Vreeker MC; Capoferri L; Geerke DP; Vermeulen NP; Commandeur JN
    Bioorg Med Chem; 2014 Oct; 22(20):5613-20. PubMed ID: 24999003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.